FoxScore

Analysis for Gilead Sciences

GILD · As of: 02/17/2026
Basic information
Type: Stock
Region: US
Sector: Health Care
TER:
History
Available history:15.0 years
Last tradingday:02/17/2026
Description & usage
Gilead Sciences develops and sells medicines, known for HIV and hepatitis treatments and with additional work in oncology and inflammation. Revenue comes from prescription drug sales through wholesalers and healthcare systems. Customers are global, with strong presence in the US and Europe.
Overall score 66Performance 60Stability 67Trend 820255075100PerformanceStabilityTrend
Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

Gilead Sciences (GILD) currently has a total score of 66 points, placing it in the strong range. The score is made up of Performance (60), Stability (67) and Trend (82). All three sub-scores are currently above average.

Performance scores 60 points (strong). Key strength: 1Y return at 45.7 %. Even the weakest return is still strong in absolute terms: 10Y return at 81.0 %. This points to a sharper upswing more recently.

Stability scores 67 points (strong). Key strength: Sharpe ratio (90d) at 2.07. Main drag: CAGR/drawdown ratio at 0.11. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 82 points (very strong). Key strength: Price is about 18.0 % above SMA50. Even the weakest metric remains solid in absolute terms: 12M momentum at 14.4 %.

Overall, the score is shaped most by Trend; Performance trails and dampens the total. On a metric level, SMA50 distance stands out, while 10Y return lags.

(Historical evaluation, not investment advice.)

Chart anzeigen
Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

FAQ

What investor type does Gilead Sciences fit best in FoxScore?
Gilead Sciences fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
How meaningful is the available history for Gilead Sciences?
Gilead Sciences currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?
FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.